EG vs ERNA · P/E 17, rev $17.28B vs P/E 0.0, rev $582.0K
Everest Group Ltd (EG) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported EG revenue for 2024-12-31 was $17.28B. Net income was $1.37B. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. EG currently screens at market cap $14.52B and trailing P/E 17.2.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
EG currently screens at market cap $14.52B and trailing P/E 17.2. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the EG and ERNA stock pages for the full models.
Not investment advice.